Trade IMMX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immix Biopharma, Inc. (IMMX) is trading at US$9.68, down 5.38% today as of Oct 2, 16:00 EDT. The company has a market capitalisation of US$972.45M. Over the past 52 weeks, IMMX has traded between US$1.99 and US$15.10. On Syfe you can trade IMMX with $0 commission and add it to your watchlist.
| Previous close | US$10.23 |
|---|---|
| Market cap | US$972.45M |
| 52-week range | US$1.99 – US$15.10 |
| Volume | 2.55M |
| Exchange | US |
Immix Biopharma, Inc.
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Year: 2021
Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating
Aug 11, 9:31 AM · MT Newswires
Needham Initiates Immix Biopharma at Buy With $21 Price Target
Jul 22, 11:19 AM · MT Newswires
Immix Biopharma, Inc. (IMMX) stock is trading at US$9.68, -5.38% from the previous close of US$10.23.
The market cap for Immix Biopharma, Inc. (IMMX) stock is approximately US$972.45M.
The 52-week high for Immix Biopharma, Inc. (IMMX) stock is US$15.10.
The 52-week low for Immix Biopharma, Inc. (IMMX) stock is US$1.99.
Immix Biopharma, Inc. (IMMX) does not currently pay a dividend.
Stay on top of IMMX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
